Antiangiogenic and Antitumor Activities of the Cryptic Fragments with Kringle Architecture |
Joe, Young-Ae
(Cancer Research Institute, Catholic Research Institutes of Medical Sciences, The Catholic University of Korea)
Kim, Myung-Rae (Cancer Research Institute, Catholic Research Institutes of Medical Sciences, The Catholic University of Korea) Shim, Byoung-Shik (Cancer Research Institute, Catholic Research Institutes of Medical Sciences, The Catholic University of Korea) Oh, Dae-Shik (Cancer Research Institute, Catholic Research Institutes of Medical Sciences, The Catholic University of Korea) Hong, Sung-Hee (Laboratory of Experimental Therapeutics, Korea Institute of Radiological and Medical Sciences) Hong, Yong-Kil (Cancer Research Institute, Catholic Research Institutes of Medical Sciences, The Catholic University of Korea) |
1 | Carmeliet, R, Dor, Y., Herbert, J. M., Fukumura, D., Brussel-mans, K., Dewerchin, M., Neeman, M., Bono, R, Abramov-itch, R., Maxwell, R, Koch, C. J., Ratcliffe, R, Moons, L., Jain, R. K., Collen, D., Keshert, E., and Keshet, E. (1998). Role of HIF-lalpha in hypoxia-mediated apoplosis. ce11 proliferation and tumour angiogenesis. Nature 394, 485-490 DOI ScienceOn |
2 | Castellino, F. J., and Beals, J. M. (1987). The genetic relationships between the kringle domains of human plasmmogen, prothrombin, lissue plasminogen activator, urokinase, and coagulation factor XII. J. Mol. Evol. 26, 358-369 DOI |
3 | Asahai-a, T., Masuda, H., Takahshi, T., Kalka, C., Paslore, C., Silver, M., Kearne, M., Magner, M., and Isner, J. M. (1999). Bone marrow origin of endothelial progenitor cells responsi-ble for postnatal vasculogenesis in physiological and Path0109-ical neovasculahzation. Circ. Res. 6; 85, 221-228 |
4 | Bergers, G., Javaherian, K., Lo, K. M., Folkman, J., and Hana-han, D. (1999). Effects of angiogenesis inhibilors on multi-slage carcmogenesis in mice. Science 284, 808-812 DOI ScienceOn |
5 | Cao, R., Wu, H. L., Veitonmaki, N., Linden, R, Famebo, J., Shi, G. Y, and Cao, Y. (1999). Suppression of angiogenesis and tumor growth by the inhibilor K1-5 generated by plasmin-mediated proteolysis. Proc. Natl. Acad. Sci. U.S.A. 96, 5728-5733 DOI ScienceOn |
6 | Cao, Y. (2001). Endogenous angiogenesis inhibitors and their thera-peutic implicadons. Int. J. Biochem. Cell Biol. 33, 357-369 DOI ScienceOn |
7 | Cao, Y., Chen, A., An, S. S., Ji, R. W., Davidson, D., and Llinas,M. (1997). Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272, 22924-22928 DOI ScienceOn |
8 | Cao, Y, Cao, R., and Veitonmaki, N. (2002). Kringle stmctnres and andangiogenesis. Curr. Med. Chem. Anti-Canc Agents 2, 667-681 DOI ScienceOn |
9 | Cao, Y, Ji, R. W., Davidson, D., Schaller, J., Marti, D., Sohndel, S., McCance, S. G., O'Reilly, M. S., Llinas, M., and Folkman, J. (1996). Kringle domains of human angiostatin. Characteriza-tion of Ihe anti-proliferative activity on endothelial cells. J. Biot. Chem. 271, 29461-29467 DOI |
10 | Folkman, J. (1995b). Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl J. Med. 333, 1757-1763 DOI ScienceOn |
11 | Fukumura, D., Xavier, R., Sugiura, T., Chen, Y, Park. E. C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., and Seed, B. (1998). Tumor induction of VEGF promoter activity in stro-mal cells. Cell 94, 715-725 DOI ScienceOn |
12 | Joe, Y. A., Hong, Y. K., Chung, D. S., Yang, Y. J., Kang, J. K., Lee, Y. S., Chang, S. I., You, W. K., Lee, H., and Chung, S. I. (1999). Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3. Int. J. Can-cer 82, 694-699 DOI ScienceOn |
13 | Kerbel, R., and Folkman, J. (2002). Clinical transladon of angio-genesis inhibitors. Nat. Rev. Cancer 2, 727-739 DOI ScienceOn |
14 | Castellino, F. J., Ploplis, V. A., Powell, J. R., and Sthckland, D. K. (1981). The existencc of independent domain structures inhuman Lys77-p1asminogen. J. Biol. Chem. 256, 4778-4782 |
15 | Claesson-Welsh, L., Welsh, M., Ito, N., Anand-Apte, B., Soker, S., Zetter, B., O'Reilly, M., and Folkman, J. (1998). Angiostatin induces endothelial cell apoptosis and activation of focal adhe-sion kinase independently of the integrin-binding motif RGD. Proc. Nall. Acd. Sci. U.S.A. 95, 5579-5583 DOI ScienceOn |
16 | Dameron, K. M., Volpert, 0. V., Tainsky, M. A., and Bouck, N. (1994). Control of angiogenesis in fibroblasts by p53 regula-tion of thrombospondin-l. Science 265, 1582-1584 DOI |
17 | Daie, K., Matsumnoto, K., Shimmra, H., Tanaka, M., and Nakainum, T. (1997). HGF/NK4 is a speciRc antagonist for pleioti-optnc actions ofhepatocyte growth factor. FEBS Lett. 420, 1-6 DOI ScienceOn |
18 | Folkman, J. (1995a). Angiugenesis in cancer, vascular, rheuma-toid and other disease. Nat. Med. 1, 27-31 DOI ScienceOn |
19 | Davies, G., Mason, M. D., Martin, T. A., Parr, C., Watkms, G., Lane, J., Matsumoto, K., Nakamura, T., and Jiang, W. G. (2003). TheHGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and anUiogenesis m vivo. Int. J. Cancer 106, 348-354 DOI ScienceOn |
20 | Dong, Z., Kumar, R., Yang, X., and Fidler, I. J. (1997). Macroph-age-derived metalloelastase is responsible for the generation ofangiostatin in Lewis lung carcinoma. CeII 88, 801-810 |
21 | Lee, H., Kim, H. K., Lee, J. H., You, W. K., Chung, S. I., Chang, S. I., Park, M. H., Hong, Y. K., and Joe, Y. A. (2000). Dismp tion of interkringle disulfide bond of plasrmnogen kringle 1 -3 changcs the lysinc binding capability of kringle 2. but not its antiangiogenic activity. Arch. Biochem. Biophys. 375, 359-363 DOI ScienceOn |
22 | Lee, T. H., Rhim, T., and Kim, S. S. (1998). Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibro-blast growth factor-stimulated capillary endothelial cells. J. Biot. Chem. 273, 28805-28812 DOI |
23 | Gately, S., Twardowski, p., Stack M. S., Cundiff, D. L., GreUa, D., Cas-tellino, F. J., Enghild, J., Kwaan, H. C.. Lee, F, Kramer, R. A., Volp-ert, 0., Bouck, N., and Soff, G. A. (1997). The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc. Nall. Acad. Sci. U.S.A. 94,10868-10872 DOI ScienceOn |
24 | Griscelli, R, Li, H., Bennaceur-Gnscelli, A., Soria, J., Opolon, R,Soria, C, Perricaudet, M., Yeh, P,, and Lu, H, (1998). Angioslatm gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. U.S.A. 95, 6367-6372 DOI ScienceOn |
25 | O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. (1996.). Angiostatin induces aiid sustains dormancy of human primary tumors in mice. Nat. Med. 2, 689-692 DOI ScienceOn |
26 | Holmgren, L,, O'Reilly, M. S., and Folkman, J. (1995). Dormancy of micrometastases: balanced proliferadon and apoptosis in the pres-ence of angiogenesis suppression. Nat. Med. 1, 149-153 DOI ScienceOn |
27 | Ji, W. R., Bamentos, L. G., Llinas, M., Gray, H., Villarreal, X., DeFord, M. E., Castellino, F. J., Kramer, R. A., and Trail, P. A. (1998a). Selective inhibition by kiingle 5 of human plasmino-gen on endothelial cell migration, an important process mangiogenesis. Biochem. Biophys. Res. Commun 247, 414-419 DOI ScienceOn |
28 | Ji, W. R., Castellino, F. J., Chang, Y., Deford, M. E., Gray, H., Villarreal, X., Kondri, M. E., Marti, D. N., Llinas, M., Schaller, J., Kramer, R. A., and Trail, P. A. (1998b). Characterization of kringle domains of angiostatin as antagonists of endoihelial cell migration, an important process in angiogenesis. FASEB J. 12 1731-1738 |
29 | O'Reilly, M. S., Holmgren, L., Shing, Y, Chen, C., Rosenthal. R. A., Moses, M., Lane, W. S., Cao, Y, Sage, E. H., and FoLkman, J. (1994). Angiostatin: a novel angiogenesis inhibitor that medi-ates the suppression of metastases by a Lewis lung carcinorna Cell 79, 315-328 DOI ScienceOn |
30 | Perez-Atayde, A. R., Sallan, S. E., Tedrow, U., Connors, S., AU-red, E., and Folkman, J. (1997). Spectrum of tumor angiogen-esis in the bone marrow of children with acute lymphoblasiic leukemia. Am. J. Pathol. 150, 815-821 |
31 | Kim, H. K., Hong, Y. K., Park, H. E, Hong, S. E., and Joe, Y. A. (2003a). Secretory production of recombinant urokmase kringle domam in Pichia pastoiis. J. Microbiol. Bwtechmt. 13, 591-597 |
32 | Kim, H. K., Lee, S. Y., Oh, H. K., Kang, B. H., Ku, H. J., Lee, Y, Shin, J. Y., Hong, Y. K., and Joe, Y. A. (2003b). Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator. Biochem. Biophys. Res. Commun 304, 740-746 DOI ScienceOn |
33 | Wajih, N., and Sane, D. C. (2002). Angiostatin selectivdy inhibits sig-naling by hepatocyte growth factor in endothelial and smooth musde cells. Blood, 2002-2002-0582 |
34 | Kim, J. S., Chang, J. H., Yu, H. K., Ahn, J. H., Yum, J. S., Lee, S. K., Jung, K. H., Park, D. H., Yoon, Y, Byun, S. M., and Chung, S. I. (2003c). Inhibition of Angiogenesis and Angiogenesis-depen-dent Tumor Growth by the Cryptic Kringle Fragments of Human Apolipoprotein(a). J. Biol. Chem. 278, 29000-29008 DOI ScienceOn |
35 | Kim, K. S., Hong, Y. K., Joe, Y. A., Lee, Y., Shin, J. Y., Park, H. E., Lee, I. H., Lee, S. Y., Kang, D. K., Chang, S. I., and Chung, S. I. (2003d). Anti-angiogemc acdvity of the recombinant krin-gle domain of urokmase and its specific entry into endothelial cells. J. BioI Chem., 278, 11449-11456 DOI ScienceOn |
36 | Kuba, K., Matsumoto, K., Date, K., Shimnura, H., Tanaka, M., and Nakamura, T. (2000). HGF/NK4, a Four-Kringle Antagonist of Hepatocyte Growth Factor, Is an Angiogenesis Inhibitor that Suppresses Tumor Growth and Metastasis in Mice. Cancer Res. 60, 6737-6743 |
37 | Xin, L., Xu, R., Zhang, Q., Li, T. P., and Gan, R. B. (2000). Ki-ingle 1 of human hepatocyte growth factor inhibits bovine aortic endolhelial cell proliferation stimulated by basic Fibroblast growlh factor and causes cell apoptosis. Biochem. Biophys. Res. Commun 277, 186-190 DOI ScienceOn |
38 | Lu, H., Dhanabal, M., Volk, R., Waterman, M. J., Ramchandran, R., Knebelmann, B., Segal, M., and Sukhatme, V. P. (1999). Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells. Biochem. Biophys. Res. Commun 258, 668-673 DOI ScienceOn |
39 | Lucas, R., Holmgren, L., Garcia, I., Jimenez, B., Mandhota, S. J., Bor-lat, F., Sim, B. K., Wu, Z., Gmu, G..E., Shing, Y, Soff. G. A., Bouck, N., and Pepper, M. S. (1998). Multiple forms of angiostatin induce apoptosis in endothelial cells. BIood 92, 4730-4741 |
40 | MacDonald, N. J., Murad, A. C., Fogler, W. E., Lu, Y, and Sim, B. K. (1999). The turnor-suppressing activity of angiostatin protein resides within kringles 1 to 3. Biochem. Biophys. Res. Commun 264, 469-477 DOI ScienceOn |
41 | Moser, T. L., Kenan, D. J., Ashley, T. A., Roy, J. A., Goodman. M. D., Misra, U. K., Cheek, D. J. P., and Salvatore, V. (2001). Endothelial cell surface Fl-FO ATP synthase is active in ATP synthesis and is inhibited by angiostaLin. PNAS 98, 6656-6661 DOI ScienceOn |
42 | Novokhatny, V. V, Kudinov, S. A., and Privalov, P. L. (1984). Domains in human plasminogen. J. Mol. Biol. 179, 215-232 DOI |
43 | O'Reilly, M. S., Boehm, T., Shing, Y, Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. CeIl 88, 277-285 DOI ScienceOn |
44 | Relf, M., LeJeune, S,, Scott, P. A., Fox, S., Smith, K., Leek, R., Moghaddam, A., Whitehouse, R., Bicknell, R., and Hanis, A. L. (1997). Expression of the angiogenic factors vascular endot-helial cell growth factor, acidic and basic fibroblast growth fac-Lor, turnor growth faclor beta-l, Platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57, 963-969 |
45 | Rhim, T. Y, Park, C. S., Kim, E,, and Kim, S. S. (1998). Human prothrombin fragment 1 and 2 inhibit bFGF-induced BCE cell growth. Biochem. Biophys. Res. Commun 252, 513-516 DOI ScienceOn |
46 | Troyanovsky, B., Levchenko, T., Mansson, G., Matvijenko, 0., and Holrngren, L. (2001). Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J. Cell Biol. 152, 1247-1254 DOI ScienceOn |
47 | Shi, Q., Rafii, S., Wu, M. H., Wijelath, E. S., Yu, C., Ishida, A., Fujita, Y, Kothari, S., Mohle, R., Sauvage, L. R., Moore. M. A. Storb, R. E, and Hammond, W. P. (1998). Evidence for circulat-ing bone marrow-derived endothelial cells. Blood 92, 362-367 |
48 | Tarui, T., Miles, L. A., and Takada, Y. (2001). Specific interaction of angiostatin with integrin a1pha(v)beta(3) in endolhelial cells. J. Biol Chem. 276, 39562-39568 DOI ScienceOn |
49 | Trexler, M., and Patthy, L. (1983). Folding autonomy of the krin-gle 4 fragment of human plasminogen. Proc. Natl Acad. Sci. U.S.A. 80, 2457-2461 DOI ScienceOn |